Moderna, Inc. is a biotechnology company that develops and commercializes messenger RNA (mRNA) therapeutics and vaccines. The company was founded in 2010 and has since become a leader in the development of mRNA-based medicines. Moderna's technology platform allows for the rapid development and production of mRNA-based drugs, which have the potential to treat a wide range of diseases, including cancer, infectious diseases, and rare genetic disorders. The company has a number of mRNA-based drugs and vaccines in development, including a COVID-19 vaccine that was granted emergency use authorization by the FDA in December 2020.